Erratum: Upregulation of miR-9 Target CBX7 Regulates Invasion Ability of Bladder Transitional Cell Carcinoma (Medical Science Monitor (2015) 21 (225-230) DOI: 10.12659/MSM.893232);Up-regulation of miR-9 target CBX7 to regulate invasion ability of bladder transitional cell carcinoma

Medical Science Monitor

Volumn 21, Issue , 2015, Pages 225-230

  Xie, Dalong ^a   Shang, Chao ^a   Zhang, Hui ^a   Guo, Yan ^a   Tong, Xiaojie ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

MicroRNAs; Neoplasm invasiveness; Urinary bladder neoplasms

Indexed keywords

CHROMOBOX HOMOLOG 7 PROTEIN; MICRORNA 9; PROTEIN; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; BMI1 PROTEIN; CBX7 PROTEIN, HUMAN; MICRORNA; MIRN92 MICRORNA, HUMAN;

ADULT; ARTICLE; BLADDER CARCINOMA; BLADDER TRANSITIONAL CELL CARCINOMA; CELL INVASION ASSAY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; EXPRESSION VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; LUCIFERASE ASSAY; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; RNA EXTRACTION; TUMOR INVASION; UPREGULATION; WESTERN BLOTTING; 3' UNTRANSLATED REGION; BIOLOGY; BLADDER; BLADDER TUMOR; CHINA; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; TRANSITIONAL CELL CARCINOMA;

3' UNTRANSLATED REGIONS; CARCINOMA, TRANSITIONAL CELL; CHINA; COMPUTATIONAL BIOLOGY; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; POLYCOMB REPRESSIVE COMPLEX 1; UP-REGULATION; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 84921320261     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.924162     Document Type: Erratum

References (30)

1. Zhao J, Xing N: Identification of g-Synuclein as a Stage-Specific Marker in Bladder Cancer by Immunohistochemistry. Med Sci Monit, 2014; 20: 2550–55
2. Murta-Nascimento C, Schmitz-Drager BJ, Zeegers MP et al: Epidemiology of urinary bladder cancer: from tumor development to patient’s death. World J Urol, 2007; 25: 285–95
3. Li W, Gu M: SULT1A1 Arg213His polymorphism is associated with bladder cancer risk: a meta-analysis. Med Sci Monit, 2014; 20: 1590–95
4. Hassen W, Droller MJ: Current concepts in assessment and treatment of bladder cancer. Curr Opin Urol, 2000; 10: 291–99
5. Lin YL, Xie PG, Ma JG: Aberrant methylation of CDH13 is a potential biomarker for predicting the recurrence and progression of non muscle invasive bladder cancer. Med Sci Monit, 2014; 20: 1572–77
6. Alečković M, Kang Y: Regulation of cancer metastasis by cell-free miRNAs. Biochim Biophys Acta, 2014; 1855(1): 24–42
7. Ullah S, John P, Bhatti A: MicroRNAs with a role in gene regulation and in human diseases. Mol Biol Rep, 2014; 41(1): 225–32
8. Tessitore A, Cicciarelli G, Del Vecchio F et al: MicroRNAs in the DNA Damage/ Repair Network and Cancer. Int J Genomics, 2014; 2014: 820248
9. Cheng CJ, Bahal R, Babar IA et al: MicroRNA silencing for cancer therapy targeted to the tumour microenvironment. Nature, 2014 [Epub ahead of print]
10. Krek A, Grun D, Poy MN et al: Combinatorial microRNA target predictions. Nat Genet, 2005; 37(5): 495–500
11. Zhang H, Qi F, Cao Y et al: Down-regulated microRNA-101 in bladder transitional cell carcinoma is associated with poor prognosis. Med Sci Monit, 2014; 20: 812–17
12. Chung TK, Lau TS, Cheung TH et al: Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1. Int J Cancer, 2011; 130(5): 1036–45
13. Shang C, Lu YM, Meng LR: MicroRNA-125b down-regulation mediates endometrial cancer invasion by targeting ERBB2. Med Sci Monit, 2012; 18(4): BR149–55
14. Zhang YF, Zhang AR, Zhang BC et al: MiR-26a regulates cell cycle and anoikis of human esophageal adenocarcinoma cells through Rb1-E2F1 signaling pathway. Mol Biol Rep, 2013; 40(2): 1711–20
15. Lei Y, Hu X, Li B et al: miR-150 modulates cisplatin chemosensitivity and invasiveness of muscle-invasive bladder cancer cells via targeting PDCD4 in vitro. Med Sci Monit, 2014; 20: 1850–57
16. Su YH, Zhou Z, Yang KP et al: MIR-142-5p and miR-9 may be involved in squamous lung cancer by regulating cell cycle related genes. Eur Rev Med Pharmacol Sci, 2013; 17(23): 3213–20
17. Gwak JM, Kim HJ, Kim EJ et al: MicroRNA-9 is associated with epithelialmesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer. Breast Cancer Res Treat, 2014; 147(1): 39–49
18. Shang C, Guo Y, Hong Y et al: MiR-21 up-regulation mediates glioblastoma cancer stem cells apoptosis and proliferation by targeting FASLG. Mol Biol Rep, 2014 [Epub ahead of print]
19. Kumar M, Singh M, Singh SB: Optimization of conditions for expression of recombinant interferon-g in E. coli. Mol Biol Rep, 2014; 41(10): 6537–43
20. Sun Z, Han Q, Zhou N et al: MicroRNA-9 enhances migration and invasion through KLF17 in hepatocellular carcinoma. Mol Oncol, 2013; 7(5): 884–94
21. Ye M, Du YL, Nie YQ et al: Overexpression of activated leukocute cell adhesion molecule in gastric cancer is associated with advanced stages and poor prognosis and miR-9 deregulation. Mol Med Rep, 2015; 11(3): 2004–12
22. Li S, Chen T, Zhong Z et al: microRNA-155 silencing inhibits proliferation and migration and induces apoptosis by upregulating BACH1 in bladder cancer cells. Mol Med Report, 2012; 5(4): 949–54
23. Krzeszinski JY, Wei W, Huynh H et al: miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2. Nature, 2014; 512(7515): 431–35
24. Shang C, Zhang H, Guo Y et al: MiR-320a down-regulation mediates bladder carcinoma invasion by targeting ITGB3. Mol Biol Rep, 2014; 41(4): 2521–27
25. Morey L, Aloia L, Cozzuto L et al: RYBP and Cbx7 define specific biological functions of polycomb complexes in mouse embryonic stem cells. Cell Rep, 2013; 3(1): 60–69
26. Forzati F, Federico A, Pallante P et al: CBX7 gene expression plays a negative role in adipocyte cell growth and differentiation. Biol Open, 2014; 3(9): 871–79
27. Shinjo K, Yamashita Y, Yamamoto E et al: Expression of chromobox homolog 7 (CBX7) is associated with poor prognosis in ovarian clear cell adenocarcinoma via TRAIL-induced apoptotic pathway regulation. Int J Cancer, 2014; 135(2): 308–18
28. Pallante P, Terracciano L, Carafa V et al: The loss of the CBX7 gene expression represents an adverse prognostic marker for survival ofcolon carcinoma patients. Eur J Cancer, 2010; 46(12): 2304–13
29. Karamitopoulou E, Pallante P, Zlobec I et al: Loss of the CBX7 protein expression correlates with a more aggressive phenotype in pancreaticcancer. Eur J Cancer, 2010; 46(8): 1438–44
30. Federico A, Pallante P, Bianco M et al: Chromobox protein homologue 7 protein, with decreased expression in human carcinomas, positively regulates E-cadherin expression by interacting with the histone deacetylase 2 protein. Cancer Res, 2009; 69(17): 7079–87